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West Nile virus (WNV) is transmitted by mosquitoes and causes fever and encephalitis in
humans, equines, and occasionally wild birds. The virus was first isolated in sub-Saharan
Africa where it is endemic. WNV lineage 1 has been responsible for repeated disease
outbreaks in the countries of the Mediterranean basin over the past 50 years. This lineage
was also introduced into North America in 1999 causing widespread human, equine, and
avian mortality. WNV lineage 2, the first WNV lineage to be isolated, was believed to be
restricted to sub-Saharan Africa causing a relatively mild fever in humans. However, in
2004, an investigation in Hungary of a case of encephalitis in a wild goshawk (Accipiter
gentiles) resulted in the isolation of WNV lineage 2. During the summer of 2004, and in
subsequent years, the virus appeared to spread locally throughout Hungary and into neigh-
boring Austria. Subsequently, WNV lineage 2 emerged in Greece in 2010 and in Italy in
2011, involving outbreaks on the Italian mainland and Sardinia. Further spread through the
Balkan countries is also suspected. Whole genome sequencing has confirmed that the
virus responsible for the outbreaks in Greece and Italy was almost identical to that isolated
in Hungary. However, unlike the outbreaks in Hungary, the burden of disease in Mediter-
ranean countries has fallen upon the human population with numerous cases of West Nile
fever and a relatively higher mortality rate than in previous outbreaks. The emergence of
WNV lineage 2 in Europe, its over-wintering and subsequent spread over large distances
illustrates the repeated threat of emerging mosquito-borne diseases.This article will review
the emergence of WNV lineage 2 in Europe; consider the pathways for virus spread and
the public health implications for the continent.
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INTRODUCTION
In recent years, arthropod-borne viruses have shown an increasing
ability to spread beyond the areas, which had been considered to
be their established geographic ranges. A number of factors are
driving this process including bird migration, increasing global
trade, and the movement of vector species (1). This range expan-
sion threatens public and livestock health. Examples of viruses that
have emerged in Europe and which are pathogenic for livestock
include bluetongue virus (2) and most recently Schmallenberg
virus (3). Such disease outbreaks incur both economic and animal
health costs that threaten the livestock industry. Other emerging
viruses are zoonotic, and the repeated emergence of West Nile
virus (WNV) in Europe is a particular example of one such range
expansion (4). The ability to detect and respond to emerging dis-
ease outbreaks, through rapid pathogen testing and host-specific
serological assays, is a key component for disease response. This
review considers the emergence of WNV lineage 2 in Europe as an
example of the threat to public and livestock health from emerging
zoonoses.
West Nile virus is classified within the genus Flavivirus, family
Flaviviridae, and is phylogenetically and antigenically related to
Japanese encephalitis virus. The virus was first isolated from the
blood of a woman suffering a febrile illness in the West Nile district
of Uganda (5). This first isolate is now believed to belong to lineage
2 suggesting its early zoonotic potential. Subsequent studies made
further isolations of WNV from human sera in Egypt (6), and
from birds and mosquitoes (7). This established that mosquitoes
were the likely virus vector and through blood-feeding on birds, the
virus was maintained in an endemic cycle. Early phylogenetic stud-
ies (discussed in more detail in subsequent sections) demonstrated
that there are two major lineages, both present in Africa (8). Subse-
quent events including the emergence of WNV in North America,
its spread throughout the western hemisphere, and repeated out-
breaks in Europe suggest that WNV has the largest distribution of
any arthropod-borne virus. In Africa, WNV is endemic and widely
distributed. Human cases have been sporadic, but environmental
conditions favoring mosquitoes, such as high diurnal tempera-
tures or frequent rainfall, have led to large epidemics (9). One such
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episode in the Karoo region of South Africa in 1974 involved tens
of thousands of human infections. Currently, approximately 5–15
human cases are confirmed each year in South Africa, however,
only a small proportion of cases undergo laboratory investiga-
tion, so this may be a considerable underestimate of the actual
number of infections (9). In horses and birds, serology studies
have demonstrated a high seroprevalence of WNV infection in
southern Africa (10, 11).
Annual late-summer outbreaks of WNV are now a regular
occurrence in European countries that border the Mediterranean
Sea and the virus is now considered endemic in some regions (12,
13). Most outbreaks have been identified as WNV lineage 1 and
were closely related to outbreaks in Israel and North America (14).
This lineage has also been responsible for deaths in humans,horses,
and avian species. Strikingly, in Africa, where lineage 2 predom-
inates, relatively few cases of neurological disease are reported,
whereas in North America and Europe, numerous human and
equine cases have occurred, leading to the suggestion that lineage
1 strains had increased pathogenicity, while lineage 2 strains were
of low virulence (9). However, experimental studies in mice (15)
and case reports (16, 17), have demonstrated that both WNV lin-
eages have the ability to cause zoonotic disease, with the potential
for fatal neuroinvasive disease. This has been realized fully with
repeated outbreaks of West Nile fever in Greece since 2010, caused
by WNV lineage 2, resulting in hundreds of human cases of West
Nile neurological disease (WNND) (18).
EMERGENCE OF WNV LINEAGE 2 IN EUROPE
The first WNV isolated in 1937 in Uganda has since been shown to
be a lineage 2 isolate, and for many years this lineage was believed to
be restricted to sub-Saharan Africa (5). Until the early 2000s,WNV
infections beyond Africa, including its emergence in North Amer-
ica, and Kunjin virus in Australia, were caused by viruses within
lineage 1 (19). This included a number of outbreaks in Europe
and countries around the Mediterranean Basin (12). Outbreaks
of West Nile disease were recorded in Algeria (1994), Morocco
and Romania (1996), Tunisia (1997), Italy (1998), Israel and Rus-
sia (1999), and France (2000). Detailed phylogenetic analysis of
viruses isolated from these outbreaks suggested that those around
the western Mediterranean were caused by a single strain, referred
to as the WMed subtype, and that this was a single introduc-
tion of virus that overwintered over a number of years (20). It was
conjectured that this sub-lineage was transferred between Mediter-
ranean countries by viremic birds, leading to the initiation of new
outbreaks. A second closely related sub-lineage included viruses
isolated from Romania and Russia, and a more divergent sub-
lineage was responsible for outbreaks in Israel and North America.
Each sub-lineage likely represents a separate introduction of WNV
into Europe from Africa.
West Nile lineage 2 was first detected in Europe in 2004 with
its isolation from the brain of a goshawk (Accipiter gentiles) in
Hungary (21). A human case of WNV lineage 2 infection was ret-
rospectively confirmed to have occurred in Russia in the same year
(22). Subsequent surveillance between 2004 and 2009 of dead birds
of prey, especially in goshawks, led to repeated isolations of the
virus across Hungary (23). The species nests and thrives in areas
of deciduous and coniferous forests and so would be targeted by
ornithophilic Culex pipiens complex mosquitoes, the main trans-
mitters of WNV in Europe. The prevalence of infection in the
northern goshawk could also result from oral transmission as this
species preys on other birds, particularly pigeons. Local spread
resulted in WNV infection of raptors in Austria (24). Subsequent
outbreaks have occurred in a number of other European countries
including Austria, Greece, Romania, Serbia, and Italy (Table 1;
Figure 1).
The outbreak in Greece has been particularly severe. The virus
was first detected in 2010 (32) in Northern Greece and devel-
oped, in contrast to the emergence in Hungary, into a large human
epidemic. The majority of cases were reported west of the city
of Thessaloniki, between the rivers Axios and Aliakmonas. Ret-
rospective serology suggests that this virus, or a related one, had
been circulating in Greece for some years prior to the first human
cases of WN fever (WNF) (33). However, this was at a low level,
<1% seropositivity, and was not accompanied by reports of dis-
ease. The first case in 2010 occurred in early July and incidence
peaked in mid-August. The last cases occurred in early October.
In total, 262 patients were recorded, with 65 classified as West Nile
fever and 197 suffered neurological disease, of which 33 died (34).
Age profiling demonstrated that the elderly were most at risk of
disease, particularly those over 70 years of age, and risk was fur-
ther increased if the individual had an existing medical condition
such as hypertension, heart disease, or diabetes. Subsequent sur-
veillance isolated WNV lineage 2 from mosquitoes (35), giving
rise to the Nea Santa-Greece 2010 strain, and from wild resident
birds (36). Epidemics of WNV lineage 2 have occurred during the
late summer in Greece in both 2011 and 2012. Further sequencing
of viruses detected in humans has confirmed that the same virus
strain is present in both humans and wildlife and has been present
in each subsequent year, suggesting endemic persistence in Greece
(37). This strain appears to cause disease in humans and wild avian
species with relatively few confirmed reports of disease in equine
species.
West Nile lineage 2 emerged in Italy in 2011, the year after
the first detection in Greece. The first reported case occurred
in a man in his late 50s in the coastal town of Ancona on the
Adriatic Sea (27). The patient reported symptoms of malaise and
Table 1 | Information on confirmed outbreaks of WNV lineage 2 in
Europe between 2004 and 2013.
Country Year Species affected Reference
Russia 2004 Human (22)
Hungary 2004–2008 Wild birds, sheep, horses,
human
(21, 23)
Austria 2008 Wild birds (24)
Greece 2010 Human, wild birds, mosquitoes (25, 26)
Romania 2010 Human
Russia 2011 Human (22)
Italy 2011 Human, wild birds, mosquitoes (27, 28)
Italy (Sardinia) 2012 Human (29–31)
Serbia 2012 Human
Italy 2013 Human
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FIGURE 1 | West Nile virus lineage 2 outbreaks in Europe. The outbreaks occurred in Hungary (1), Austria (2), Greece (3), Italy (4), Sardinia (5), Russia (6),
Serbia (7), and Romania (8). Map data: Google maps.
fever early in September, and was admitted to hospital. With the
patient reporting no history of travel outside of Italy, this was
considered an autochthonous case. Shortly after this, six cases
of neurological disease due to WNV lineage 2 were reported in
Sardinia between September and October, 2011 (28). Mosquito
surveillance for WNV detected lineage 2 in Cx. pipiens mosquito
pools and in a collared dove (Streptopelia decaocto) in northern
Italy, where lineage 1 has been endemic since 2008 (38). Detections
of WNV lineage 2 in Italy have continued in subsequent years, and
have included further human cases (29, 31). As in Greece, instances
of WNV infection in horses in Italy are rare.
West Nile fever was detected in humans in Romania in 2010
and Serbia in 2012. In Romania 57 cases were reported, 54 with
neuroinvasive disease (26). In Serbia, 58 patients were confirmed
infected (30). Of these, 52 developed neuroinvasive disease and
9 died. Virus isolation and phylogenetic analysis confirmed that
both outbreaks were due to WNV lineage 2 (26, 39).
There is currently no vaccine against WNV licensed for human
use, and although WNV lineage 2 has not been detected in coun-
tries in northern Europe, travelers to affected areas during the
periods of vector activity are at risk of infection. This was illus-
trated by a human case of WNV infection in a 73 years-old Belgian
woman who was visiting Greece in the summer of 2012 (40). Fol-
lowing her return to Belgium, samples of serum and cerebrospinal
fluid were both positive for WNV IgM and IgG. The serum sam-
ple, taken 29 days after development of fever, was positive for WNV
by real-time RT-PCR. A 116 base pair sequence derived from the
amplicon was highly suggestive of the presence of WNV lineage 2.
Bird migration has been considered one of the major drivers
for translocation of WNV (41–43). The emergence of WNV lin-
eage 2 in Hungary followed by dissemination, both locally and
to countries to the south could have resulted from translocation
through infected bird movements. Two of the regions where the
virus has emerged are dominated by wetland areas, namely the
Po Delta in north-east Italy and the Aliakmonas Delta in northern
Greece (44). Such areas attract migrating birds moving north from
Africa and then returning south again from breeding grounds in
central Europe. These areas are also associated with abundant pop-
ulations of Cx. pipiens complex mosquitoes. Surveillance in these
areas has detected WNV in pools of Cx. pipiens, and to a lesser
extent Cx. modestus (45). This could drive the spread of WNV to
indigenous bird species and eventually lead to spill-over infection
in humans and horses. This coalescence of events, bird migration,
landing periods in wetland areas, and peak vector abundance are
needed to stimulate emergence, hence human cases tend to occur
in late summer. The repeated emergence of WNV lineage 2 over
subsequent summers suggests that over-wintering is occurring,
supported mainly by phylogenetic evidence (20), although this is
by no means conclusive as local re-introductions could give the
same result. If over-wintering is occurring then this would likely
be through infected adult females, the primary means of survival
of Culex mosquitoes from 1 year to the next. The prevalence of
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virus within the population would gradually increase through the
subsequent summer, although always remaining at low levels rela-
tive to the total population of mosquitoes, but triggering spill-over
infection in humans during late summer.
DISEASE CAUSED BY WNV LINEAGE 2 IN EUROPE
West Nile virus infection is typically asymptomatic. However, a
febrile self-limiting illness is reported in around 20% of infected
humans and is associated with headaches, myalgia, nausea, vom-
iting, and chills. A papular rash is reported in some cases, but
generally symptoms resolve within 7 days (46–48). In approxi-
mately 1% of cases, WNV will enter the central nervous system,
infecting neurons and cause neuroinvasive disease (49, 50). Neuro-
logical forms are varied and can include encephalitis, meningitis,
meningoencephalitis, or acute flaccid paralysis (49). Symptoms
are exacerbated by old age and immunosuppression. A follow-up
study from the 2010 Greece epidemic reported anorexia, muscle
weakness, memory loss, and depression to be the most common
sequelae in a group of elderly patients who suffered from WNND.
Only 31.8% (7/22) patients recovered fully (48–50).
Equines have been reported to be susceptible to lineage 2 strains,
with an increased risk of developing WNND. Clinical signs in
horses include ataxia, weakened limbs, paresis, complete paralysis,
seizures, chewing, partial blindness, and jaundice/hepatitis (16).
Lineage 2 has been reported with varying mortality across the
affected regions. The reasons for this may be linked to the previ-
ously characterized threonine 249 to proline (T249P) substitution
within the NS3 gene, which was present in WNV isolates responsi-
ble for the Greek outbreak but not the Hungarian or Italian isolates
(16, 51). However, an Italian strain identical to the Nea Santa-
Greece 2010 strain (with T249P) was reported from the Veneto
region of Italy, although there has been an absence of human
disease as had been observed in Greece (25, 52). The Romanian
outbreak of WNV lineage 2 in 2010 had an 8.8% fatality rate with
57 cases of WNND compared to a previous outbreak of WNV
lineage 1 in 1996, which had a 4.4% fatality rate.
PHYLOGENY OF WNV LINEAGE 2 AND STRAIN VARIATION
West Nile virus has a single-stranded RNA genome of approx-
imately 11 kb in length. The genome encodes three structural
proteins and seven non-structural proteins. A large number of
complete WNV genomes have now been sequenced and can be
used for phylogenetic comparison with emerging viruses. This
has greatly assisted in the investigation of the likely origins of
WNV emergence. The 2004 lineage 2 WNV strain was isolated
from a wild goshawk (Accipiter gentiles) in Hungary, and the
genomic sequence of this isolate demonstrated closest homology
with a group of southern African strains (53). The introduction of
WNV lineage 2 into the wetlands of Hungary could have occurred
through migratory birds that had become infected in Africa and
remained sufficiently viremic during migration to infect mos-
quitoes in Europe on arrival (23). However, the goshawk is not
considered a migratory bird, suggesting that this African lineage
2 strain must have been transmitted by local mosquitoes prior to
detection in 2004.
Genetic characterization of the lineage 2 strain detected in
Greece confirmed that it was most closely related to the strain
that had previously emerged in Hungary (25). Similarly, strains
detected in Serbia in 2012 were most closely related to strains pre-
viously identified in Greece, Hungary, and Italy (39). The strains
detected in Italy in 2013 show closest homology with lineage 2
strains isolated in Italy in 2011 and Austria in 2008 (27). These
observations suggest that the spread of lineage 2 throughout
Europe was due to spread of the 2004 Hungarian strain, rather
than from separate incursions via migratory birds from Africa.
Migratory birds could also have played a role in the spread of lin-
eage 2 WNV in Europe during the southerly migration. During
autumn, turtle doves (Streptopelia turtur) migrate from breeding
areas in central Europe to wintering areas in Africa, and serolog-
ical studies on individual birds on their arrival in resting areas
of Greece suggest that they were exposed to WNV lineage 2 in
the area of origin in central Europe, and may constitute a candi-
date for introduction of lineage 2 strains from central Europe to
Greece (37).
The mutation T249P within non-structural protein 3 (NS3) of
Greek lineage 2 strains is similar to that observed in neuroinvasive
lineage 1 isolates (51), while analysis of Italian strains isolated in
2013 has identified a number of amino acid substitutions including
E638K and D831G within the NS5 protein (51). Figure 2 highlights
the relationship between lineage 2 strains detected in Europe, and
the southern African strains from which they may have originated.
The isolates used for phylogenetic analysis are detailed in Table 2.
The figure demonstrates the close homology between strains from
Italy, Austria, Greece, Serbia, and Hungary (marked by a bracket),
with clear divergence between these strains and strains from Africa
and Russia, suggesting that lineage 2 WNV might now circulate in
a separate enzootic cycle within Europe. A number of these viruses
FIGURE 2 | Phylogeny of WNV lineage 2 in Europe and Africa. The
neighbor-joining tree was generated from an alignment of complete WNV
genomes (10,350 base pairs) using MEGA 5 software. Each sequence
identifier represents the country of origin and the year of isolation. Further
details on each virus are provided inTable 2. Bootstrap values are shown at
key nodes and were derived from 1000 replicates. The divergent virus
MAD-78 is used as an outgroup.
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Table 2 | Details of WNV lineage 2 sequences used for phylogenetic analysis in Figure 2.
Sequence ID GenBank accession no. Original ID Species Country Year
Hu-04 DQ116961 Goshawk-Hungary/04 Accipiter gentilis Hungary 2004
Gr-10 HQ537483 Nea Santa-Greece 2010 Culex pipiens Greece 2010
Gr-12 KF179639 Greece/2012/Kavala.39.1 Human Greece 2012
It-13 KF588365 Italy/2013/Rovigo/32.1 Human Italy 2013
It-11 JN858070 Italy/2011/AN-2 Human Italy 2011
Au-08 KF179640 Austria/2008-gh Accipiter gentilis Austria 2008
Ser-10 KC496016 Novi Sad-2010 Culex pipiens Serbia 2010
Rus-07 FJ425721 Reb_VLG_07_H Human Russia 2007
SA-89 EF429197 SPU116/89 Human South Africa 1989
SA-01 EF429198 SA93/01 Human South Africa 2001
CAR-72 DQ318020 ArB3573/82 Culex tigripes Central African Republic 1972
SA-58 EF429200 H442 Human South Africa 1958
SA-00 EF429199 SA381/00 Human South Africa 2000
Mad-78 DQ176636 Madagascar-AnMg798 Coracopsis vasa Madagascar 1978
were derived from human cases, confirming the zoonotic nature
of these outbreaks.
MOSQUITO SPECIES ASSOCIATED WITH DISEASE
TRANSMISSION: THE CASE FOR EMERGENCE IN THE UNITED
KINGDOM
Outbreaks of WNV are associated with abundant populations of
mosquitoes, which can occur as a result of flooding and subsequent
dry and warm weather, or formation of suitable larval breeding
habitats (54). Although WNV has been isolated from over 40
species of mosquitoes, the principal mosquitoes involved in WNV
transmission belong to the genus Culex, particularly species in the
Cx. pipiens complex (55, 56). Two species are formally recognized
in the complex, Cx. pipiens (northern, temperate regions) and Cx.
quinquefasciatus (southern, tropical regions) (57). In the UK, the
subgenus Culex is represented by the nominotypical Cx. pipiens
(58), which include two forms, Cx. pipiens f. pipiens and Cx. pipi-
ens f. molestus. In addition, Cx. torrentium and Cx. europaeus are
also recorded in the UK (59). These species are fairly common
and widespread, with the exception of Cx. europaeus, for which
few records are available. A further species, Cx. modestus, was also
believed to be rare in the UK (59). However, recent inventories of
UK mosquito fauna have revealed that populations of Cx. modes-
tus are well established and commonly found in the North Kent
marshes (60, 61).
The occurrence and abundance of potential vector species
are a prerequisite for enzootic transmission of mosquito-borne
viruses in the UK. Thirty-four species of mosquitoes have been
recorded in the British Isles, of which nine species have been
implicated in WNV transmission elsewhere (62). Thirteen species
are likely to be bridge vectors as they readily bite both birds and
humans. In Britain, the ecology of, and the potential risk of WNV
transmission by, mosquito species have been detailed by several
authors (62–64).
Cx. pipiens sensu stricto (s.s.) bite both humans and birds; the
two forms within this species are morphologically indistinguish-
able, but they are physiologically different. Cx. pipiens f. pipiens
is mostly ornithophagic and rarely bite humans, the immature
stages are found in permanent water, it overwinters in the adult
stage and is multivoltine (62). By contrast, Cx. pipiens f. molestus
is highly anthropophilic (though it may bite birds), the immature
stages live underground (e.g., flooded basements, sewer tunnels,
underground railway systems), and all life stages occur through-
out the year (63). The females can be nuisance biters in winter.
Medlock et al. (64) stated that the form molestus might pose a
threat for WNV transmission in suburban and rural areas. Where
both forms are sympatric, hybridization can result (65, 66). This
leads to increased numbers of mammophilic mosquitoes that can
affect transmission of WNV (67). In the UK, the increased use
of water containers in private gardens has also been cited as a
possible factor that could lead to increases in mosquito abun-
dance in urban areas that in turn could lead to more nuisance
biting and increase the risk of WNV maintenance should it be
introduced (68).
Golding et al. (60) showed that Cx. modestus accounted for
73% of all mosquito species from all sites sampled in the county
of Kent and was collected in strong association with Anopheles
maculipennis sensu lato (s.l.). Although the risk of WNV trans-
mission to humans in the UK is still low due to limited human
exposure to bridge vectors, the risk for transmission was higher in
Kent because of the presence of other bridge vector species such as
Cx. pipiens s.l. and both migratory and resident birds. The authors
highlighted the potential risk for horses, which are often grazed
in this part of country. At present, screening of specimens of Cx.
modestus for WNV and other flaviviruses such as Usutu virus is
being undertaken by cross-governmental groups in the UK under
a “One Health” initiative.
INVASIVE MOSQUITO SPECIES
The increase in human population, expansion of trading routes
and tourism, deforestation, and climate change are some of the
factors that have facilitated the rapid dispersal of vector species
into new geographical areas (69). Recent emergence of bluetongue
virus and outbreaks of WN fever and Chikungunya fever in Europe
are just a few examples of the risk of exotic vector-borne pathogens
being transported to a new region (69).
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For invasive mosquitoes in Europe, six exotic species have been
identified (Aedes aegypti, Ae. albopictus, Ae. atropalpus, Ae. japon-
icus, Ae. koreicus, and Ae. triseriatus). These have mainly been
imported through the international trade in used tires and Lucky
bamboo, although public and/or private ground transport have
also been implicated. Of these, Ae. albopictus presents the greatest
threat. Female Ae. albopictus lay desiccation-resistant eggs above
the surface of the water in tree holes, tires, or other water-holding
containers (70). Its ability to breed in artificial containers has
facilitated its spread in recent decades along major transporta-
tion routes. Currently, Ae. albopictus is considered one of the top
100 invasive species of mosquitoes worldwide (71).
Aedes albopictus is a known vector of CHIKV, and laboratory
infectious studies have shown that this species is a competent
vector of WNV (72). It has been recorded in 20 European coun-
tries including the Netherlands and Belgium (its northernmost
latitude) (73), although it has not been recorded in the UK. Sur-
veillance for this and other invasive mosquito species should be
a priority as their presence would radically change the risk of virus
emergence.
CONCLUSION
West Nile virus lineage 2 was introduced into Europe in 2004 and
subsequently emerged in a number of countries. It has overwin-
tered in these countries and in the case of Italy is co-circulating
with WNV lineage 1 and Usutu virus. Migratory birds are likely to
be the main vehicle of movement for the virus, both as a source
of introduction and the means by which it has spread within
Europe. However, there is little direct evidence to support this.
The disease manifestations appear to vary in different countries.
In Hungary, raptors appear to be affected while in Greece the
main burden of disease has fallen on the human population. The
reasons for this are not clear, but the variation could be caused
by mutations within particular virus strains that persist in dif-
ferent locations. The abundance and composition of mosquito
populations, particularly Culex species, are critical for the spread
of disease. Further study of factors such as mosquito distribu-
tion, host biting preference, and species hybridization will improve
understanding of WNV persistence and assessment of the risk to
human populations.
Following detection of WNV, there is a need to implement pub-
lic health measures to protect at risk populations, particularly the
elderly. This includes measures to reduce mosquito biting such
as destruction of larval habitats and applications of larvicides.
Measures that protect the individual include the application of
mosquito repellents and clothing that reduces the exposure of bare
skin. Currently, there is no human vaccine available. The risk of
further spread of WNV lineage 2 to countries around the Mediter-
ranean Sea is high. Countries in northern Europe appear to be at
lower risk due to reduced mosquito abundance and lower winter
temperatures. However, constant vigilance is needed to monitor
for any change in environmental or ecological conditions that
could make the introduction and persistence of WNV in northerly
latitudes possible.
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